As a key immune checkpoint protein, PD-L1 binds to the PD-1 receptor on the surface of T cells and activates co-inhibitory signal transduction to inhibit the function of cytotoxic T lymphocytes, leading to immunosuppression and enabling tumor cells to evade the surveillance and attack of the immune system [52, 53]. The gene discussed is CD274; the disease is neoplasm.